WangBi Granules
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for WangBi Granules, covering 2025-01-20 to 2025-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis [Phase 4]